PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Oct-2023 Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions Coriolis Pharma
17-Oct-2023 Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society Secarna Pharmaceuticals GmbH & Co. KG
17-Oct-2023 Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox Amerigo Scientific
17-Oct-2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA ImmunOs Therapeutics
17-Oct-2023 Defence Therapeutics Inc.: DELIVERY OF ENCAPSULATED ACCUTOXTM-CHITOSAN NANOPARTICLES TRIGGERS COMPLETE TUMOR REGRESSION IN ANIMALS WITH PRE-ESTABSLIHED SOLID LYMPHOMA Defence Therapeutics Inc.
17-Oct-2023 Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume Marinomed Biotech AG
17-Oct-2023 Capital Markets Day 2023: New Mid-Term Guidance 2024 – 2028 Supported by Ramp-Up of Growth Projects Lonza Group AG
16-Oct-2023 Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder Teva Pharmaceuticals
16-Oct-2023 Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised Drägerwerk AG & Co. KGaA
16-Oct-2023 Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing ABIVAX
16-Oct-2023 ‘Strategic alliances’ in pharma and biotech: innovation through cooperation Bachem
16-Oct-2023 Navin Fluorine International Ltd. launches Navin Molecular: The new brand for its future-thinking CDMO business Navin Molecular
16-Oct-2023 Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions B3C newswire
16-Oct-2023 Douglas GmbH: DOUGLAS will pay interest on PIK notes in cash Douglas GmbH
13-Oct-2023 PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million PAION AG
13-Oct-2023 PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million PAION AG
13-Oct-2023 Almirall's lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis (AD) in patients inadequately controlled with or ineligible for cyclosporine1 Almirall S.A.
13-Oct-2023 ABB and ODS partnership to enable precise and reliable custody transfer ABB
13-Oct-2023 RTW Biotech Opportunities Ltd Monthly Valuation Update, September Factsheet & Third Quarter Letter RTW Biotech Opportunities Ltd
13-Oct-2023 Cerba Research Announces New Collective Focus on Transforming Research and Advancing Health Cerba Research